IRadimed CorporationIRMDNASDAQ
Loading
EBITDA Margin Over TimeStrong
Percentile Rank85
3Y CAGR+3.6%
5Y CAGR+79.3%
Studio
Year-over-Year Change

EBITDA as a percentage of revenue

3Y CAGR
+3.6%/yr
vs +7.0%/yr prior
5Y CAGR
+79.3%/yr
Recent deceleration
Acceleration
-3.3pp
Decelerating
Percentile
P85
Within normal range
vs 5Y Ago
18.5x
Strong expansion
Streak
1 yr
Consecutive growthStrong
PeriodValueYoY Change
202534.04%+9.4%
202431.11%-2.0%
202331.73%+3.8%
202230.58%+13.9%
202126.84%+1361.1%
20201.84%-92.8%
201925.68%+9.9%
201823.35%+107.8%
201711.24%-67.3%
201634.37%-